Lb Pharmaceuticals Inc · NASDAQ:LBRX
TCG Crossover GP II, LLC reported a 7.80% stake in Lb Pharmaceuticals Inc (Schedule 13G)
Event Sep 12, 2025 · Filed Sep 18, 2025
TCG Crossover GP II, LLC reported a 7.80% stake in Lb Pharmaceuticals Inc, 1,745,015 shares, as a passive investor on Sep 12, 2025. Filed Sep 18, 2025 (Schedule 13G).
- Stake
- 7.80%
- Shares
- 1,745,015
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 7.80% | 1,745,015 |
| TCG Crossover Fund II, L.P. | 7.80% | 1,745,015 |
| Chen Yu | 7.80% | 1,745,015 |
Source
Related
- Lb Pharmaceuticals Inc
- TCG Crossover GP II, LLC
- Lb Pharmaceuticals Inc shareholders
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · May 15, 2026
- Schedule 13G/A · JPMorgan Chase & Co · Oct 13, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 29, 2026
- Schedule 13G · JPMorgan Chase & Co · Jul 16, 2026
- Schedule 13G · Caligan Partners LP · May 15, 2026
- Schedule 13G/A · Commodore Capital LP · May 15, 2026